This report documents a female patient with stage IIIb rectal squamous cell carcinoma receiving definitive chemoradiation therapy with 5-FU/mitomycin/XRT who developed severe toxicity to 5-FU secondary to a 2R/2R polymorphism in the TYMS gene. Here, TYMS is linked to squamous cell carcinoma of rectum.